Oxford COVID-19 vaccine programme opens for clinical trial recruitment
University of Oxford researchers working in an unprecedented vaccine development effort to prevent COVID-19 have started screening healthy volunteers (aged 18-55) for their upcoming ChAdOx1 nCoV-19 vaccine trial in the Thames Valley Region. The vaccine based on an adenovirus vaccine vector and the SARS-CoV-2 spike protein is already in production but won’t be ready for some weeks still.
Source: World Pharma News - Category: Pharmaceuticals Tags: Featured Development Research and Development Source Type: news
More News: Adenoviruses | Clinical Trials | COVID-19 | Oxford University | Pharmaceuticals | SARS | Vaccines